title: Imminent ischemia in normal and hypertrophic Langendorff rat hearts; effects of fatty acids and superoxide dismutase monitored by NADH surface fluorescence.
abstract: Hypertrophic hearts contain areas of hypoperfusion which can be visualized by increased NADH surface fluorescence during in vitro perfusion without oxygen-carrying particles under constant pressure and pacing. By contrast, fluorescence remained low when non-hypertrophic hearts were used instead. When during perfusion of normal hearts the pH of the medium was lowered from 7.5 to 7.0, areas of high fluorescence appeared in a few minutes. The high fluorescent areas under conditions of cardiac hypertrophy or pH 7.0 perfusion could be reduced by addition of superoxide dismutase. It indicates that oxygen free radicals interfere with proper flow regulation in areas of low pH. Fluorescence in hypertrophic hearts also diminished during addition of albumin-bound oleate to the standard, glucose-containing, medium. This is in agreement with our earlier finding of fatty acid protection from acidosis-initiated loss of capillary flow (Biochim. Biophys. Acta, 1033 (1990) 214-218). In contrast to low concentrations of free fatty acids, high concentrations interfere with tissue oxygenation. This has been illustrated by the use of 1 mM octanoate, which after a few min caused the appearance of high fluorescent areas. We conclude that decompensation of flow in hypoperfused areas of heart, as occurs in hypertrophy, may be stimulated by acidosis and oxygen free radicals.
authors.affiliation: Department of Surgery, Erasmus University, Rotterdam, The Netherlands.
authors.forename: W C
authors.initials: WC
authors.lastname: Hulsmann
authors.forename: J F
authors.initials: JF
authors.lastname: Ashruf
authors.forename: H A
authors.initials: HA
authors.lastname: Bruining
authors.forename: C
authors.initials: C
authors.lastname: Ince
mesh_terms: D000138:Acidosis / Q000378:metabolism; D000818:Animals; D002210:Caprylates / Q000494:pharmacology; D006332:Cardiomegaly / Q000150:complications* / Q000378:metabolism; D003327:Coronary Disease / Q000209:etiology*; D005227:Fatty Acids / Q000494:pharmacology*; D005453:Fluorescence; D006863:Hydrogen-Ion Concentration; D008297:Male; D009243:NAD / Q000032:analysis*; D010477:Perfusion; D051381:Rats; D017208:Rats, Wistar; D013482:Superoxide Dismutase / Q000494:pharmacology*
chemical_list: D002210:Caprylates; D005227:Fatty Acids; D009243:NAD; D013482:Superoxide Dismutase; C031492:octanoic acid